| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 5 securities · passive | ||||||
|
Wolfspeed, Inc.
13G
WOLF · 97785W106
|
10.0% |
5/15/2026
Event 3/31/2026
|
||||
| Slate Path Capital LP | 10.0% | |||||
| David Greenspan | 10.0% | |||||
|
Rocket Companies, Inc.
13G
RKT · 77311W101
|
2.0% |
10/21/2025
Event 9/30/2025
|
||||
| Slate Path Capital LP | 2.0% | |||||
| David Greenspan | 2.0% | |||||
|
Tvardi Therapeutics, Inc.
13G
TVRD · 140755307
|
7.5% |
8/14/2025
Event 6/30/2025
|
||||
| Slate Path Capital LP | 7.5% | |||||
| David Greenspan | 7.5% | |||||
|
Cue Biopharma, Inc.
13G/A
CUE · 22978P106
|
1.4% |
2/14/2025
Event 12/31/2024
|
||||
| Slate Path Capital LP | 1.4% | |||||
| David Greenspan | 1.4% | |||||
|
Cyclerion Therapeutics, Inc.
13G/A
CYCN · 23255M204
|
0% |
12/6/2024
Event 11/30/2024
|
||||
| Slate Path Capital LP | 0% | |||||
| David Greenspan | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.